Illness	Number of cases
Hyperplasia of prostate (N40)	102
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	92
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	91
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	84
Cystitis (N30.0)	52
Calculus of kidney and ureter - Calculus of kidney (N20.0)	46
Malignant neoplasm of prostate (C61)	43
Calculus of kidney and ureter - Calculus of ureter (N20.1)	34
Unspecified haematuria (R31)	33
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by renal calculi (N13.20)	22

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	297
Examination of the urethra and the urinary bladder by endoscopy (1-661)	182
(1-999.40)	173
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	165
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0)	124
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	118
Insertion, exchange or removal of a ureteral stent (8-137.00)	118
(9-984.8)	81
(9-984.7)	80
Insertion, exchange or removal of a ureteral stent (8-137.10)	74

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Osteoporose

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ31

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
46	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
31	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
22	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility